Loading…
Zydus Lifesciences (ZYDUSLIFE)₹1,216+1.37%Pharmaceuticals
At the end of the Jun 2026 quarter, Zydus Lifesciences' shareholders were: promoters 75.07%, FIIs 6.88%, DIIs 11.30%, public 6.75%. Promoter holding is up 0.02 percentage points from 75.05% a quarter earlier. FII holding is down 0.24 percentage points from 7.12% a year earlier. 0.00% of promoter shares were pledged. It had 3,99,336 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 75.03% | 75.03% | 75.03% | 75.03% | 75.03% | 75.03% | 75.05% | 75.05% | 75.05% | 75.05% | 75.05% | 75.07% |
| FIIs | 4.84% | 4.98% | 5.71% | 5.58% | 7.51% | 7.52% | 7.30% | 7.12% | 7.33% | 7.05% | 6.94% | 6.88% |
| DIIs | 13.04% | 12.99% | 12.58% | 12.59% | 10.62% | 10.64% | 10.98% | 11.12% | 10.89% | 11.11% | 11.23% | 11.30% |
| Government | 0.07% | 0.07% | 0.07% | 0.07% | 0.05% | 0.05% | 0.05% | 0.04% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 7.02% | 6.93% | 6.61% | 6.73% | 6.79% | 6.76% | 6.62% | 6.67% | 6.73% | 6.79% | 6.78% | 6.75% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 2,98,017 | 3,06,560 | 2,94,387 | 3,36,381 | 3,70,942 | 3,65,434 | 3,71,698 | 3,86,209 | 3,96,189 | 4,03,352 | 4,18,403 | 3,99,336 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Zydus Family Trust (Pankaj R. Patel, Pritiben P. Patel and Sharvil P. Patel-Trustees) | Promoter | 74.94% | +0.02 |
| Life Insurance Corporation Of India | DII | 5.42% | −0.15 |
| Parag Parikh Flexi Cap Fund | DII | 2.01% | +0.06 |
| Kotak Flexicap Fund | DII | 1.20% | +0.06 |
| Arati Rajiv Mehta | Promoter | 0.01% | 0.00 |
Promoters held 75.07% of Zydus Lifesciences at the end of the Jun 2026 quarter, up 0.02 percentage points from 75.05% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 6.88% (down 0.06 percentage points from 6.94% a quarter earlier) and domestic institutions (DIIs) held 11.30% (up 0.07 percentage points from 11.23% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Zydus Lifesciences had 3,99,336 shareholders at the end of the Jun 2026 quarter, against 3,86,209 a year earlier.
Life Insurance Corporation Of India (DII) held 5.42% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.